Oxidative stress in critically ill patients;Estrés oxidativo en el paciente crítico

Revista Medica de Chile

Volumn 134, Issue 5, 2006, Pages 649-656

  Andresen H, Max ^a,b   Regueira H, Tomás ^a,c   Leighton, Federico ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b MSSC Intensive Care ^*  (Chile)

^c Universidad Católica

Author keywords

Multiple organ failure; Oxidative stress; Reactive oxygen specias

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; REACTIVE OXYGEN METABOLITE;

CRITICAL ILLNESS; DNA DAMAGE; DRUG EFFECT; HUMAN; INTENSIVE CARE; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; REVIEW; SEPSIS;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CRITICAL CARE; CRITICAL ILLNESS; DNA DAMAGE; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEPSIS;

EID: 33745674500     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. ZENI F, FREEMAN B, NATANSON C. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 1997; 25: 1095-100.
2. TAYLOR DE, GHIO AJ, PIANTADOSI CA. Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch Biochem Biophys 1995; 316: 70-6.
3. SZABO C, CUZZOCREA S, ZINGARELLI B, O'CONNOR M, SALZMAN AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997; 100: 723-35.
4. CUZZOCREA S, RILEY DP, CAPUTI AP, SALVEMINI D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53: 135-59.
5. YAMAKURA F, TAKA H, FUJIMURA T, MURAYAMA K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998; 273: 14085-9.
6. VAN DER VLIET A, SMITH D, O'NEILL CA, KAUR H, DARLEY-USMAR V, CROSS CE ET AL. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 1994; 303: 295-301.
7. CUZZOCREA S, ZINGARELLI B, CAPUTI AP. Role of peroxynitrite and poly (ADP-ribosyl) synthetase activation in cardiovascular derangement induced by zymosan in the rat. Life Sci 1998; 63: 923-33.
8. VATASSERY GT. Oxidation of vitamin E, vitamin C, and thiols in rat brain synaptosomes by peroxynitrite. Biochem Pharmacol 1996; 52: 579-86.
9. MACARTHUR H, WESTFALL TC, RILEY DP, MISKO TP, SALVEMINI D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 2000; 97: 9753-8.
10. SALVEMINI D, WANG ZQ, ZWEIER JL, SAMOUILOV A, MACARTHUR H, MISKO TP ET AL. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999; 286: 304-6.
11. SALVEMINI D, RILEY DP, LENNON PJ, WANG ZQ, CURRIE MG, MACARTHUR H ET AL. Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br J Pharmacol 1999; 127: 685-92.
12. NISHINO T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem 1994; 116: 1-6.
13. DALLE-DONNE I, GIUSTARINI D, COLOMBO R, ROSSI R, MILZANI A. Protein carbonylation in human diseases. Trends Mol Med 2003; 9: 169-76.
14. MOSKOVITZ J, POSTON JM, BERLETT B, NOSWORTHY N, SZCZEPANOWSKI R, STADTMAN E. Identification and characterization of a putative active site for peptide methionine sulfoxide reductase (MsrA) and its substrate stereospecificity. J Biol Chem 2000; 275: 14167-72.
15. MOHRI M, REINACH PS, KANAYAMA A, SHIMIZU M, MOSKOVITZ J, HISATSUNE T ET AL. Suppression of the TNFalpha-induced increase in IL-1alpha expression by hypochlorite in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2002; 43: 3190-5.
16. MASHIMA R, NAKANISHI-UEDA T, YAMAMOTO Y. Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry. Anal Biochem 2003; 313: 28-33.
17. HOSHI T, HEINEMANN S. Regulation of cell function by methionine oxidation and reduction. J Physiol 2001; 531(Pt 1): 1-11.
18. MELOV S, COSKUN P, PATEL M, TUINSTRA R, COTTRELL B, JUN AS ET AL. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 1999; 96: 846-51.
19. BAYNE AC, SOHAL RS. Effects of superoxide dismutase/catalase mimetics on life span and oxidative stress resistance in the housefly, Musca domestica. Free Radic Biol Med 2002; 32: 1229-34.
20. HO CT, CHAN AC. Regeneration of vitamin E in rat polymorphonuclear leucocytes. FEBS Lett 1992; 306: 269-72.
21. GALLI F. Vitamin C, vitamin E and immune response. J Nutr Biochem 2005; 16: 257.
22. GOODE HF, COWLEY HC, WALKER BE, HOWDLE PD, WEBSTER NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23: 646-51.
23. TAKEDA K, SHIMADA Y, AMANO M, SAKAI T, OKADA T, YOSHIYA I. Plasma lipid peroxides and alpha-tocopherol in critically ill patients. Crit Care Med 1984; 12: 957-9.
24. RICHARD C, LEMONNIER F, THIBAULT M. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit Care Med 1990; 18: 4-9.
25. METNITZ PG, BARTENS C, FISCHER M, FRIDRICH P, STELTZER H, DRUML W. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25: 180-5.
26. CROSS CE, FORTE T, STOCKER R, LOUIE S, YAMAMOTO Y, AMES BN, FREI B. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med 1990; 115: 396-404.
27. KELLY FJ. Vitamin E supplementation in the critically ill patient: too narrow a view? Nutr Clin Pract 1994; 9: 141-5.
28. SCHORAH CJ, DOWNING C, PIRIPITSI A, GALLIVAN L, ALHAZAA AH, SANDERSON MJ ET AL. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63: 760-5.
29. PASCUAL C, KARZAI W, MEIER-HELLMANN A, OBERHOFFER M, HORN A, BREDLE D ET AL. Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 1998; 26: 705-9.
30. GALLEY HF, DAVIES MJ, WEBSTER NR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996; 24: 1649-53.
31. WINTERBOURN CC, BUSS IH, CHAN TP, PLANK LD, CLARK MA, WINDSOR JA. Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit Care Med 2000; 28: 143-9.
32. ANZUETO A, ANDRADE FH, MAXWELL LC, LEVINE SM, LAWRENCE RA, JENKINSON SG. Diaphragmatic function after resistive breathing in vitamin E-deficient rats. J Appl Physiol 1993; 74: 267-71.
33. BULGER EM, MAIER RV. An argument for vitamin E supplementation in the management of systemic inflammatory response syndrome. Shock 2003; 19: 99-103.
34. RITTER C, ANDRADES ME, REINKE A, MENNA-BARRETO S, MOREIRA JC, DAL-PIZZOL F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 2004; 32: 342-9.
35. GALLEY HF, HOWDLE PD, WALKER BE, WEBSTER NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 1997; 23: 768-74.
36. PREISER JC, VAN GOSSUM A, BERRE J, VINCENT JL, CARPENTIER Y. Enteral feeding with a solution enriched with antioxidant vitamins A, C, and E enhances the resistance to oxidative stress. Crit Care Med 2000; 28: 3828-32.
37. GADEK JE, DEMICHELE SJ, KARLSTAD MD, PACHT ER, DONAHOE M, ALBERTSON TE ET AL. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999; 27: 1409-20.
38. NATHENS AB, NEFF MJ, JURKOVICH GJ, KLOTZ P, FARVER K, RUZINSKI JT ET AL. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236: 814-22.
39. BERGER MM, SHENKIN A. Trace elements in trauma and burns. Curr Opin Clin Nutr Metab Care 1998; 1: 513-7.
40. ANGSTWURM MW, SCHOTTDORF J, SCHOPOHL J, GAERTNER R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999; 27: 1807-13.
41. CUZZOCREA S, ZINGARELLI B, O'CONNOR M, SALZMAN AL, SZABO C. Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure. Br J Pharmacol 1998; 123: 525-37.
42. PATERSON RL, GALLEY HF, WEBSTER NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2003; 31: 2574-8.
43. HELLER AR, GROTH G, HELLER SC, BREITKREUTZ R, NEBE T, QUINTEL M, KOCH T. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med 2001; 29: 272-6.
44. LEFF JA, PARSONS PE, DAY CE, TANIGUCHI N, JOCHUM M, FRITZ H. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993; 341: 777-80.
45. LASSNIGG A, PUNZ A, BARKER R, KEZNICKL P, MANHART N, ROTH E ET AL. Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth 2003; 90: 148-54.